FormulaFolio Investments’s Elevance Health ELV Stock Holding History

FormulaFolio Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1K	Buy	+3	New	+$1.15K	﹤0.01%	461
2021 Q1	–	Sell	-2,248	Closed	-$723K	–	430
2020 Q4	$722K	Buy	+2,248	New	+$690K	0.02%	381
2020 Q3	–	Sell	-1,659	Closed	-$436K	–	323
2020 Q2	$436K	Buy	1,659 +671	+68%	+$179K	0.02%	198
2020 Q1	$224K	Sell	988 -668	-40%	-$182K	0.01%	256
2019 Q4	$500K	Sell	1,656 -2,456	-60%	-$676K	0.02%	240
2019 Q3	$987K	Buy	4,112 +471	+13%	+$129K	0.04%	155
2019 Q2	$1.03M	Buy	3,641 +2,196	+152%	+$600K	0.04%	137
2019 Q1	$415K	Buy	+1,445	New	+$418K	0.02%	220

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FormulaFolio Investments's ELV Position: Q2 2021 in Review

FormulaFolio Investments opened a new position in Elevance Health (ELV) in Q2 2021: 3 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: FormulaFolio Investments previously reported a position in ELV as recently as Q4 2020.

FormulaFolio Investments first reported a position in ELV in Q1 2019 and has held it in 8 quarters since. The position peaked at $1.03M in Q2 2019. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

FormulaFolio Investments held 3 shares of Elevance Health worth $1K as of Q2 2021.
Elevance Health was a new FormulaFolio Investments position in Q2 2021.
Elevance Health made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #461 holding.
FormulaFolio Investments first reported a position in Elevance Health in Q1 2019 and has held it in 8 quarters since.
FormulaFolio Investments's Elevance Health position peaked at $1.03M in Q2 2019.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.